Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 46, 2011 - Issue 2
Submit an article Journal homepage
46
Views
5
CrossRef citations to date
0
Altmetric
Letters to the Editor

Accelerated progression of hepatocellular carcinoma with cytokeratin 19 expression during treatment with lamivudine for hepatitis B virus-related liver cirrhosis

Masayoshi Yamada Department of Gastroenterology, Kanazawa Medical University, Ishikawa, JapanCorrespondence[email protected]
,
Hisakazu Shiroeda Department of Gastroenterology, Kanazawa Medical University, Ishikawa, Japan
,
Katsuaki Sato Department of Pathology II, Kanazawa Medical University, Ishikawa, Japan
,
Ranji Hayashi Department of Gastroenterology, Kanazawa Medical University, Ishikawa, Japan
,
Tomoe Nomura Department of Gastroenterology, Kanazawa Medical University, Ishikawa, Japan
,
Mikihiro Tsutsumi Department of Gastroenterology, Kanazawa Medical University, Ishikawa, Japan
&
Tomiyasu Arisawa Department of Gastroenterology, Kanazawa Medical University, Ishikawa, Japan
 show all
Pages 249-251 | Received 03 Sep 2010, Accepted 05 Sep 2010, Published online: 19 Oct 2010

References

  • Uenishi T, Kubo S, Yamamoto T, Shuto T, Ogawa M, Tanaka H, Cytokeratin 19 expression in hepatocellular carcinoma predicts early postoperative recurrence. Cancer Sci 2003;94:851–7.
  • Aishima S, Nishihara Y, Kuroda Y, Taguchi K, Iguchi T, Taketomi A, Histologic characteristics and prognostic significance in small hepatocellular carcinoma with biliary differentiation: subdivision and comparison with ordinary hepatocellular carcinoma. Am J Surg Pathol 2007;31:783–91.
  • Durnez A, Verslype C, Nevens F, Fevery J, Aerts R, Pirenne J, The clinicopathological and prognostic relevance of cytokeratin 7 and 19 expression in hepatocellular carcinoma. A possible progenitor cell origin. Histopathology 2006;49:138–51.
  • Liaw YF, Sung JJ, Chow WC, Farrell G, Lee CZ, Yuen H, Lamivudine for patients with chronic hepatitis B and advanced liver disease. N Engl J Med 2004;351:1521–31.
  • Matsumoto A, Tanaka E, Rokuhara A, Kiyosawa K, Kumada H, Omata M, Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients. Hepatol Res 2005;32:173–84.
  • Ikai I, Arii S, Okazaki M, Okita K, Omata M, Kojiro M, Report of the 17th Nationwide Follow-up Survey of Primary Liver Cancer in Japan. Hepatol Res 2007;37:676–91.
  • Roberts KE, Hamele-Bena D, Saqi A, Stein CA, Cole RP. Pulmonary tumor embolism: a review of the literature. Am J Med 2003;115:228–2.
  • Uenishi T, Yamazaki O, Yamamoto T, Hirohashi K, Tanaka H, Tanaka S, Clinical significance of serum cytokeratin-19 fragment (CYFRA 21-1) in hepatocellular carcinoma. J Hepatobiliary Pancreat Surg 2006;13:239–44.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.